Cargando…
Thapsigargin at Non-Cytotoxic Levels Induces a Potent Host Antiviral Response that Blocks Influenza A Virus Replication
Influenza A virus is a major global pathogen of humans, and there is an unmet need for effective antivirals. Current antivirals against influenza A virus directly target the virus and are vulnerable to mutational resistance. Harnessing an effective host antiviral response is an attractive alternativ...
Autores principales: | Goulding, Leah V., Yang, Jiayun, Jiang, Zhimin, Zhang, Hongyu, Lea, Daniel, Emes, Richard D., Dottorini, Tania, Pu, Juan, Liu, Jinhua, Chang, Kin-Chow |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600819/ https://www.ncbi.nlm.nih.gov/pubmed/32992478 http://dx.doi.org/10.3390/v12101093 |
Ejemplares similares
-
Emergent SARS-CoV-2 variants: comparative replication dynamics and high sensitivity to thapsigargin
por: Al-Beltagi, Sarah, et al.
Publicado: (2021) -
Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus
por: Al-Beltagi, Sarah, et al.
Publicado: (2021) -
Thapsigargin: key to new host-directed coronavirus antivirals?
por: Shaban, Mohammed Samer, et al.
Publicado: (2022) -
Scalable Synthesis of (−)-Thapsigargin
por: Chu, Hang, et al.
Publicado: (2016) -
Nerve growth factor blocks thapsigargin-induced apoptosis at the level of the mitochondrion viaregulation of Bim
por: Szegezdi, E, et al.
Publicado: (2008)